Elevated Capital Advisors LLC Buys Shares of 1,607 Danaher Co. (NYSE:DHR)

Elevated Capital Advisors LLC bought a new stake in shares of Danaher Co. (NYSE:DHR) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 1,607 shares of the conglomerate’s stock, valued at approximately $247,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Global Retirement Partners LLC increased its stake in shares of Danaher by 1.4% in the 4th quarter. Global Retirement Partners LLC now owns 4,443 shares of the conglomerate’s stock worth $682,000 after purchasing an additional 62 shares in the last quarter. Wedge Capital Management L L P NC boosted its holdings in Danaher by 4.2% in the 4th quarter. Wedge Capital Management L L P NC now owns 1,593 shares of the conglomerate’s stock worth $244,000 after buying an additional 64 shares during the period. Parkside Financial Bank & Trust boosted its holdings in Danaher by 7.0% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,027 shares of the conglomerate’s stock worth $158,000 after buying an additional 67 shares during the period. WealthPLAN Partners LLC boosted its holdings in Danaher by 2.0% in the 3rd quarter. WealthPLAN Partners LLC now owns 3,580 shares of the conglomerate’s stock worth $491,000 after buying an additional 70 shares during the period. Finally, Everett Harris & Co. CA boosted its holdings in Danaher by 0.6% in the 4th quarter. Everett Harris & Co. CA now owns 12,115 shares of the conglomerate’s stock worth $1,859,000 after buying an additional 70 shares during the period. Institutional investors and hedge funds own 77.91% of the company’s stock.

DHR opened at $165.95 on Friday. The firm has a 50-day simple moving average of $159.87 and a two-hundred day simple moving average of $146.23. Danaher Co. has a 52 week low of $110.63 and a 52 week high of $169.19. The company has a market capitalization of $117.38 billion, a PE ratio of 34.77, a price-to-earnings-growth ratio of 2.58 and a beta of 0.92. The company has a quick ratio of 4.86, a current ratio of 5.19 and a debt-to-equity ratio of 0.75.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, January 30th. The conglomerate reported $1.28 EPS for the quarter, beating the consensus estimate of $1.25 by $0.03. Danaher had a net margin of 15.09% and a return on equity of 11.50%. The business had revenue of $4.87 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the prior year, the firm earned $1.28 EPS. The business’s revenue was up 5.7% on a year-over-year basis. As a group, sell-side analysts expect that Danaher Co. will post 5.45 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.41%. The ex-dividend date was Thursday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 15.38%.

In related news, CFO Matthew Mcgrew sold 11,304 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $161.98, for a total value of $1,831,021.92. Following the completion of the transaction, the chief financial officer now owns 21,320 shares of the company’s stock, valued at approximately $3,453,413.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Angela S. Lalor sold 18,267 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $161.49, for a total transaction of $2,949,937.83. Following the completion of the transaction, the senior vice president now directly owns 56,782 shares of the company’s stock, valued at approximately $9,169,725.18. The disclosure for this sale can be found here. Insiders have sold a total of 271,015 shares of company stock valued at $43,928,132 in the last three months. Insiders own 11.40% of the company’s stock.

Several research analysts recently weighed in on the stock. Wells Fargo & Co assumed coverage on shares of Danaher in a report on Tuesday, January 7th. They issued an “overweight” rating and a $170.00 target price for the company. JPMorgan Chase & Co. upped their target price on shares of Danaher from $155.00 to $175.00 in a report on Thursday, December 19th. Cowen reaffirmed a “buy” rating and issued a $170.00 target price on shares of Danaher in a report on Monday, February 3rd. Citigroup upped their target price on shares of Danaher from $180.00 to $195.00 and gave the stock a “buy” rating in a report on Friday, January 31st. Finally, Stifel Nicolaus upped their target price on shares of Danaher from $150.00 to $162.00 and gave the stock a “hold” rating in a report on Friday, January 31st. One research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have assigned a buy rating to the company. Danaher has a consensus rating of “Buy” and an average price target of $166.37.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: Differences Between Momentum Investing and Long Term Investing

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.